Newamsterdam Pharma Co Nv (NAMS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.017% |
| Hold Price * : | $33.89 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q2 2026 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 49.46% | 1,081,400 | 0.33 | |
| Q1 2026 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 15.42% | 292,176 | 0.11 | |
| ≡ | Polen Capital Management | Sell 100.00% | 11,239 | 0.00 | |
| Q4 2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 25.88% | 389,479 | 0.15 | |
| ≡ | Polen Capital Management | Buy | 11,239 | 0.00 | |
| ≡ | Viking Global Investors | Reduce 35.09% | 2,271,967 | 0.21 | |
| Q3 2025 | |||||
| ≡ | Viking Global Investors | Reduce 7.21% | 503,000 | 0.04 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 1.77% | 27,127 | 0.01 | |
| Q2 2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 178.79% | 982,405 | 0.28 | |
| Q1 2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 56.99% | 199,464 | 0.07 | |
| Q4 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 350,005 | 0.16 | |
| ≡ | Viking Global Investors | Reduce 13.04% | 1,046,031 | 0.09 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Add 22.99% | 1,500,000 | 0.06 | |
| Q2 2023 | |||||
| ≡ | Viking Global Investors | Add 66.62% | 2,608,695 | 0.13 | |
| Q1 2023 | |||||
| ≡ | Viking Global Investors | Add 4.32% | 162,042 | 0.01 | |
| Q4 2022 | |||||
| ≡ | Viking Global Investors | Buy | 3,753,828 | 0.20 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.